{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:40:03Z","timestamp":1759848003947,"version":"3.37.3"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["18AG020"],"award-info":[{"award-number":["18AG020"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cyto.2023.156357","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T14:49:36Z","timestamp":1694184576000},"page":"156357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Importance of screening severe COVID-19 patients for IFN-\u03bb1, IL-6 and anti-S1 IgG levels"],"prefix":"10.1016","volume":"171","author":[{"given":"Olcay Buse","family":"Kenano\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayt\u00fcl","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fcseyin","family":"Can","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammet","family":"Karakavuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedef","family":"Erkunt Alak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fclay","family":"Korukluo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fe Ba\u015fak","family":"Alta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fcsn\u00fc","family":"Pulluk\u00e7u","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysu","family":"De\u011firmenci D\u00f6\u015fkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu\u011fba","family":"Karakavuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ceren","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candan","family":"\u00c7i\u00e7ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Sezai","family":"Ta\u015fbakan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ak\u0131n","family":"\u00c7inkoo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cemal","family":"\u00dcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan Y\u00fcksel","family":"G\u00fcr\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmut","family":"Avc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erc\u00fcment","family":"Karasulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eaban","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mert","family":"D\u00f6\u015fkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meltem","family":"I\u015f\u0131kg\u00f6z Ta\u015fbakan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cyto.2023.156357_b0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"unstructured":"WHO. COVID-19 Dashboard. Geneva: World Health Organization, 2022, https:\/\/covid19.who.int\/ (last accession: 07 July 2023).","key":"10.1016\/j.cyto.2023.156357_b0010"},{"issue":"5","key":"10.1016\/j.cyto.2023.156357_b0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2023.156357_b0020","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/s41591-021-01500-9","article-title":"Calming the cytokine storm in COVID-19","volume":"27","author":"Cron","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cyto.2023.156357_b0025","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cyto.2023.156357_b0030","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"1","author":"Hojyo","year":"2020","journal-title":"Inflamm. Regen."},{"issue":"1","key":"10.1016\/j.cyto.2023.156357_b0035","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12967-020-02571-x","article-title":"Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study","volume":"18","author":"Zhang","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cyto.2023.156357_b0040","article-title":"Anti-interleukin-6 therapies for hospitalized patients with COVID-19: a protocol for a prospective meta-analysis of randomized trials","author":"Who","year":"2021","journal-title":"World Health Organization"},{"issue":"10","key":"10.1016\/j.cyto.2023.156357_b0045","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.cyto.2023.156357_b0050","doi-asserted-by":"crossref","first-page":"e1008515","DOI":"10.1371\/journal.ppat.1008515","article-title":"Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells","volume":"16","author":"Santer","year":"2020","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.cyto.2023.156357_b0055","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41577-020-00429-3","article-title":"The type I interferon response in COVID-19: implications for treatment","volume":"20","author":"Lee","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"10229","key":"10.1016\/j.cyto.2023.156357_b0060","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cyto.2023.156357_b0065","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa2209760","article-title":"Early treatment with pegylated interferon lambda for Covid-19","volume":"388","author":"Reis","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.cyto.2023.156357_b0070","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.cyto.2023.156357_b0075","doi-asserted-by":"crossref","first-page":"e02107","DOI":"10.1128\/JCM.02107-20","article-title":"Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate","volume":"58","author":"Addetia","year":"2020","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"10.1016\/j.cyto.2023.156357_b0080","doi-asserted-by":"crossref","first-page":"e0252818","DOI":"10.1371\/journal.pone.0252818","article-title":"Corona virus disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging","volume":"16","author":"Schaefer","year":"2021","journal-title":"PLoS One"},{"unstructured":"Turkish Ministry of Health, COVID-19 (SARS-CoV-2 Enfeksiyonu) Eri\u015fkin Hasta Tedavisi, https:\/\/covid19.saglik.gov.tr\/Eklenti\/43095\/0\/covid-19rehberieriskinhastayonetimivetedavi-12042022pdf.pdf.","key":"10.1016\/j.cyto.2023.156357_b0085"},{"issue":"1","key":"10.1016\/j.cyto.2023.156357_b0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s13277-015-3829-9","article-title":"Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer","volume":"37","author":"Erturk","year":"2016","journal-title":"Tumour Biol."},{"unstructured":"Mayo Clinic Laboratories, Interleukin 6, Plasma. https:\/\/www.mayocliniclabs.com\/test-catalog\/overview\/618776.","key":"10.1016\/j.cyto.2023.156357_b0095"},{"issue":"1","key":"10.1016\/j.cyto.2023.156357_b0100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"16","key":"10.1016\/j.cyto.2023.156357_b0105","doi-asserted-by":"crossref","first-page":"2000421","DOI":"10.2807\/1560-7917.ES.2020.25.16.2000421","article-title":"Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020","volume":"25","author":"Perera","year":"2020","journal-title":"Euro Surveill."},{"key":"10.1016\/j.cyto.2023.156357_b0110","first-page":"493","article-title":"Simple method of estimating fifty percent end points","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"unstructured":"WHO. Laboratory Procedures Serological detection of avian influenza A(H7N9) infections by microneutralization assay, https:\/\/www.who.int\/publications\/m\/item\/serological-detection-of-avian-influenza-a(h7n9)-infections-by-microneutralization-assay (23 May 2013).","key":"10.1016\/j.cyto.2023.156357_b0115"},{"doi-asserted-by":"crossref","unstructured":"L. Yang, X. Xie, Z. Tu, J. Fu, D. Xu, Y. Zhou, The signal pathways and treatment of cytokine storm in COVID-19, Signal. Transduct. Target. Ther. 6(1) (2021) 255. 10.1038\/s41392-021-00679-0. Erratum in: Signal. Transduct. Target Ther. 6(1) (2021) 326.","key":"10.1016\/j.cyto.2023.156357_b0120","DOI":"10.1038\/s41392-021-00679-0"},{"issue":"1","key":"10.1016\/j.cyto.2023.156357_b0125","doi-asserted-by":"crossref","first-page":"20793","DOI":"10.1038\/s41598-021-00190-0","article-title":"Cytokine signature and COVID-19 prediction models in the two waves of pandemics","volume":"11","author":"Cabaro","year":"2021","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.cyto.2023.156357_b0130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41590-019-0408-z","article-title":"Interferon-\u03bb modulates dendritic cells to facilitate T cell immunity during infection with influenza A virus","volume":"20","author":"Hemann","year":"2019","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2023.156357_b0135","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012465","article-title":"COVID-19: lambda interferon against viral load and hyperinflammation","volume":"12","author":"Andreakos","year":"2020","journal-title":"EMBO Mol Med."},{"issue":"1","key":"10.1016\/j.cyto.2023.156357_b0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","article-title":"Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison","volume":"22","author":"Galani","year":"2021","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156357_b0145","doi-asserted-by":"crossref","first-page":"e544","DOI":"10.1002\/hsr2.544","article-title":"Interleukin-29 profiles in COVID-19 patients: Survival is associated with IL-29 levels","volume":"5","author":"Fallah Vastani","year":"2022","journal-title":"Health Sci. Rep."},{"issue":"4","key":"10.1016\/j.cyto.2023.156357_b0150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.it.2021.02.003","article-title":"Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation","volume":"42","author":"King","year":"2021","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2023.156357_b0155","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2023.156357_bib156","doi-asserted-by":"crossref","first-page":"155478","DOI":"10.1016\/j.cyto.2021.155478","article-title":"Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review","volume":"142","author":"Liu","year":"2021","journal-title":"Cytokine"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623002351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623002351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T10:07:19Z","timestamp":1736417239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466623002351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":32,"alternative-id":["S1043466623002351"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156357","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Importance of screening severe COVID-19 patients for IFN-\u03bb1, IL-6 and anti-S1 IgG levels","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156357"}}